5-Amino-1MQ
Metabolic health
Small-molecule NNMT inhibitor; not a peptide. Adipose metabolism and metabolic dysfunction in experimental models.
Not FDA-approved
Integrated Wellness · The science, in context
Understand the molecule. Question the claim.
Explore peptides and related molecules through mechanisms, published research and what we still don’t know. Clear science. No sales. No shortcuts.
A better research lens
A promising mechanism is the beginning of a question—not the end of one.
Cells & models
What might happen?
Human studies
What happens in people?
Clinical outcomes
Does it meaningfully help?
Regulatory context
For which product and use?
A more visual way to learn
Start with recovery, metabolism or longevity. Build your vocabulary, explore the biology and keep track of what you’ve read.
The research directory
35 of 35 molecules
Metabolic health
Small-molecule NNMT inhibitor; not a peptide. Adipose metabolism and metabolic dysfunction in experimental models.
Not FDA-approved
Metabolic health
Modified growth-hormone fragment. Whether a GH-derived fragment can influence lipid metabolism without reproducing all GH effects.
Not FDA-approved
Tissue repair
Synthetic pentadecapeptide (15 amino acids). Tendon, ligament, muscle and gastrointestinal injury models.
Not FDA-approved
Hormonal signaling
Long-acting GHRH analog. GH and IGF-1 responses and pharmacokinetics in controlled research.
Not FDA-approved
Metabolic health
Investigational semaglutide–cagrilintide combination. Combined GLP-1 and amylin signaling for metabolic outcomes.
Not FDA-approved
Metabolic health
Long-acting amylin analog. Appetite regulation and body-weight outcomes in controlled studies.
Not FDA-approved
Sleep & circadian
Delta sleep-inducing nonapeptide. Historical sleep architecture and stress-response hypotheses.
Not FDA-approved
Cognitive research
Angiotensin-IV-derived peptidomimetic. Synaptic plasticity and cognitive behavior in experimental models.
Not FDA-approved
Longevity
Synthetic AEDG tetrapeptide. Telomerase, telomere maintenance and pineal-related biology.
Not FDA-approved
Longevity
D-retro-inverso research peptide. Selective removal of senescent cells in laboratory models.
Not FDA-approved
Skin science
Copper-binding tripeptide complex. Topical skin remodeling and extracellular-matrix biology.
Not FDA-approved as a drug
Hormonal signaling
Synthetic growth-hormone-releasing peptide (pralmorelin). Human endocrine responses and GH-stimulation testing.
Not FDA-approved
Hormonal signaling
Synthetic hexapeptide secretagogue. GH secretion and related endocrine feedback.
Not FDA-approved
Hormonal signaling
Synthetic hexapeptide secretagogue. Pituitary endocrine responses compared with ghrelin and GHRH.
Not FDA-approved
Longevity
Mitochondrial-derived peptide. Cell survival and neuroprotection hypotheses.
Not FDA-approved
Muscle performance
Modified long-acting IGF-1 analog. Growth-factor signaling in cell culture and animal models.
Not FDA-approved
Hormonal signaling
Synthetic pentapeptide secretagogue. GH signaling and gastrointestinal motility research.
Not FDA-approved
Gut health
Lys-Pro-Val tripeptide related to alpha-MSH. Intestinal inflammatory signaling and experimental colitis.
Not FDA-approved
Hormonal signaling
Kisspeptin decapeptide fragment. Reproductive hormone signaling and GnRH/LH responses.
Not FDA-approved
Immune pathways
Human cathelicidin antimicrobial peptide. Antimicrobial defense, wound biology and immune signaling.
Not FDA-approved
Metabolic health
Mitochondrial-derived 16-amino-acid peptide. Metabolic stress, insulin sensitivity and skeletal-muscle signaling.
Not FDA-approved
Skin science
Nonselective melanocortin receptor agonist. Pigmentation and historical sexual-function research.
Not FDA-approved
Cognitive research
CNTF-derived research-peptide label. Neurogenesis and cognition in preclinical research.
Not FDA-approved
Muscle performance
Pegylated MGF-related research construct. Muscle progenitor-cell and growth-factor biology.
Not FDA-approved
Hormonal signaling
Bremelanotide; melanocortin receptor agonist. Sexual-desire outcomes within a narrowly defined clinical indication.
FDA-approved product · narrow indication
Metabolic health
Investigational triple-receptor agonist. Body-weight and metabolic outcomes in controlled trials.
Not FDA-approved
Longevity
Elamipretide; mitochondria-targeted tetrapeptide. Mitochondrial membrane function and disease-specific outcomes.
FDA accelerated approval · Barth syndrome
Cognitive research
Synthetic tuftsin-related heptapeptide. Anxiety-related signaling and neurobehavioral hypotheses.
Not FDA-approved
Metabolic health
GLP-1 receptor agonist. Glycemic, weight and cardiovascular outcomes in defined patient groups.
FDA-approved products · specific indications
Cognitive research
Synthetic ACTH-fragment analog. Neuropeptide signaling and neurological research hypotheses.
Not FDA-approved
Hormonal signaling
GHRH (1–29) analog. Pituitary GH response and historical pediatric GH-deficiency research.
Historical FDA product · discontinued
Tissue repair
Thymosin-beta-4-related fragment label. Cell migration and tissue-repair hypotheses.
Not FDA-approved
Metabolic health
GHRH analog. Visceral adipose tissue in adults with HIV-associated lipodystrophy.
FDA-approved product · narrow indication
Immune pathways
Thymosin alpha-1 (thymalfasin), a 28-amino-acid peptide. Immune regulation in infection and other disease-specific studies.
Not FDA-approved
Metabolic health
Dual GIP/GLP-1 receptor agonist. Glycemic and weight outcomes and other labeled disease-specific outcomes.
FDA-approved products · specific indications
Entries may appear in more than one category. Category placement describes research interest, not proven benefit. This is a curated selection, not a systematic review; source gaps are identified inside each profile.
Beyond the library
Explore our broader health optimization approach. A library entry does not mean a molecule is offered, prescribed, or appropriate for you.
Continue to our existing activation & intake page.
Education, not a prescription. Research summaries are not medical advice, dosing instructions, or an offer to sell. Mechanistic findings do not establish clinical effectiveness. US regulatory status is product- and indication-specific and may change. Discuss health decisions with a licensed clinician.